Physician profile
Gresham T Richter
NPI 1093858581
$3,526.05
in general payments reported to CMS, 2019-2025
7 companies · $905 in 2025
The $905 reported for 2025 was more than what 84% of Pediatric Otolaryngology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.20 · 2023: $94.27 · 2024: $2,509 · 2025: $905.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,000 · Food and Beverage: $509.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,000.00 |
| Food and Beverage | $508.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $3,000.00 | 2024-2025 | |
| Grace Medical, INC. | $155.43 | 2025 | |
| Preceptis Medical, INC. | $131.59 | 2024 | Hummingbird Tympanostomy Tube System |
| Kls-Martin L.P. | $94.27 | 2023 | |
| Nsk America Corporation | $74.10 | 2024 | |
| Integra Lifesciences Corporation | $53.46 | 2024 | Integra, Integra Duo, Instruments-Orthopedic |
| Amniox Medical, INC. | $17.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gresham Richter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.